Texas Attorney General Ken Paxton has filed a second legal action against Kenvue and Johnson & Johnson, seeking to block a $400 million dividend payout that he argues would hinder the state’s’ ability to recover potential civil penalties tied to…

CMS is launching a pilot program aimed at lowering prescription drug costs in Medicaid by aligning prices with those paid in other developed countries. The program is set to begin in January.  “CMS is making a historic commitment to driving…

The FDA awarded six additional products a Commissioner’s National Priority Voucher, bringing the total number of recipients to 15, according to a Nov. 6 news release. The pilot program aims to reduce drug review timelines to as short as two…

Within four years, the End Drug Shortages Alliance has expanded to 100 active members, including hospitals, group purchasing organizations and drug manufacturers and distributors.  Vizient and Angels for Change, a drug supply nonprofit, created the alliance in 2021, according to…

Medicare will begin covering weight loss drugs in 2026 for the first time under a pricing agreement announced by the White House, according to a Nov. 6 press release. The agreements with Eli Lilly and Novo Nordisk apply most-favored-nation pricing…

Pfizer and Novo Nordisk’s bidding war for the weight loss drugmaker Metsera is intensifying. Five updates: 1. Pfizer matched Novo Nordisk’s $10 billion bid for the biotech firm Nov. 5, one day after Novo’s $86.20 per share offer, sources told…

Walgreens has launched the Walgreens Pharmacy Patient Advisory Board to guide development of pharmacy services with direct input from patients managing chronic or complex conditions. Patient members will serve one-year terms, while advocacy advisors will serve two-year terms, according to…

The FDA has approved Linzess capsules for treating irritable bowel syndrome with constipation in pediatric patients seven years and older, according to a Nov. 5 news release. Here are five things to know: 1.  Linzess is now the first treatment…

As the healthcare industry continues to evolve, it is more important than ever to embrace strategies that improve outcomes, lower costs, and create a better experience for patients. One strategy that is gaining momentum is the integration of medical and…

A federal court denied AbbVie’s request to halt enforcement of a new law protecting contract pharmacies under the 340B Drug Pricing Program in Colorado. On Oct. 31, the U.S. District Court for the District of Colorado denied the drugmaker’s motion…